Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jul 19, 2024

SELL
$0.71 - $0.97 $4,360 - $5,956
-6,141 Closed
0 $0
Q3 2023

Jul 19, 2024

SELL
$0.96 - $2.01 $5,123 - $10,727
-5,337 Reduced 46.5%
6,141 $6.01 Million
Q4 2022

Jul 19, 2024

BUY
$2.06 - $3.47 $23,644 - $39,828
11,478 New
11,478 $24.8 Million

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $992M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Pathway Financial Advisers, LLC Portfolio

Follow Pathway Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathway Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathway Financial Advisers, LLC with notifications on news.